Saturday 17 October 2026 Export VKTX’s income statement to Excel — free account

Viking Therapeutics, Inc.

In the quarter to June 2026, EPS fell 89.7% and free cash flow fell 166.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

25.17 2.20 −8.04%

Follow VKTX

Alert me

Market cap: $3.5B
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(29.23%)	(47.34%)	(70.04%)	(88.85%)
ROA Full definition →		(28.31%)	(44.29%)	(64.04%)	(79.24%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(33.31%)	(56.29%)	(94.11%)	(131.11%)
Free Cash Flow per Share Full definition →		(2.00)	(2.47)	(2.94)	(3.60)
Free Cash Flow Full definition →		(224.58)	(278.68)	(340.33)	(418.44)
Other line items
Cash ROIC Full definition →		(15.73%)	(20.72%)	(30.80%)	(45.98%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.95	0.77	0.72	0.78
Depreciation/Fixed assets Full definition →		0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(2.00)	(2.47)	(2.94)	(3.60)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly